Annexon, Inc.

NASDAQ:ANNX

Biotechnology

Healthcare
$3.52 -0.71%

-$0.04 today

Market cap
$576.73M
Beta
1.18
P/E (TTM)
-4.8
EPS (TTM)
-$1.01
52W Low $1.85High $7.18

Volume 2.98M

Average 2.56M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$186.36M

FY 2025 · Annual

Investing Cash Flow

$190.05M

FY 2025 · Annual

Financing Cash Flow

$108.86M

FY 2025 · Annual

-32.5% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(130.32M)(141.95M)(134.24M)(138.2M)(206.69M)
Depreciation & Amortization3.41M2.11M2.15M2.15M2.17M
Deferred Income Tax00000
Stock-Based Compensation018.52M18.18M19.43M16.42M
Change in Working Capital3.28M3.74M(5.81M)6.36M4.23M
Accounts Receivables00000
Inventory00000
Accounts Payables3.86M(287K)(2.08M)4.94M4.49M
Other Working Capital(575K)4.03M(3.73M)1.43M(261K)
Other Non-Cash Items17.52M1.28M(1.43M)(7.75M)(2.49M)
Operating Cash Flow(106.11M)(116.31M)(121.14M)(118.01M)(186.36M)
Capital Expenditures(1.65M)(6.53M)(193K)(15K)(137K)
Acquisitions (Net)0(64.97K)000
Purchases of Investments(225.6M)(113.2M)(108.09M)(583.93M)(212.21M)
Sales of Investments139.02M178.17M178.98M365.15M402.4M
Other Investing Activities064.97K000
Investing Cash Flow(88.24M)58.44M70.7M(218.8M)190.05M
Debt Repayment00000
Common Stock Issued1.8M130.48M135.51M161.87M110.47M
Common Stock Repurchased00000
Dividends Paid0000(1.86M)
Other Financing Activities0(7.57M)14K(665K)238K
Financing Cash Flow1.8M122.91M135.52M161.21M108.86M
Effect of Forex Changes(1.17M)1K5K(15K)2K
Net Change in Cash(193.72M)65.04M85.09M(175.61M)112.55M
Free Cash Flow(107.76M)(122.84M)(121.34M)(118.02M)(186.49M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$206.7M
+ D&A$2.2M
+ Stock-Based Comp$16.4M
+ Deferred Tax$0
+ Working Capital$4.2M
- Other Non-Cash-$2.5M
= Operating Cash Flow-$186.4M
- Capex-$137.0K
= Free Cash Flow-$186.5M

Analysis

FY2025 free cash flow is -$186.5M. FCF conversion is 90.2% of net income. Operating cash flow was -$186.4M, with capex of -$137.0K. The largest bridge item is Stock-Based Comp at $16.4M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 9, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
4Statement of changes in beneficial ownershipSep 25, 2026
3Initial statement of beneficial ownershipAug 12, 2026

Does ANNX generate free cash flow?

Annexon, Inc. (ANNX) generated -$186.49M of free cash flow in fiscal 2025.

How much operating cash flow does ANNX produce?

Operating cash flow was -$186.36M, before capital expenditures of $137,000.00.